Shigella vaccine (LimmaTech Biologics)

N/A

Report date: 2024/10/18 17:37:54

Base Information

Drug NameShigella vaccine (LimmaTech Biologics)
Drug Alias NameMultivalent Shigella vaccineVaccine biconjugate Shigella dysenteriaeShigella vaccine - GlycoVaxynShigella multivalent vaccineShigella flexneri 2a vaccine +[15] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerlandKenya
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlycovaxyn Ag
China Registration ClassN/A

Develop Information

Active CompaniesLimmatech Biologics AgValneva SE
Inactive CompaniesGlycovaxyn Ag
Active IndicationsDysentery, Bacillary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A